This multiplicity of targets, which is a typical feature of other antitumor RNases [59], results in pleiotropic effects, ranging from cell growth inhibition to pro-apoptotic activity [57], and suggests that RNase-L can play a protective effect on tumor progression and participate in the survival advantage in female melanoma patients. The gene discussed is RNASEL; the disease is melanoma.